qfx

This acquisition elevates their ownership to 1.59% of the fund’s reportable AUM – a statistic that, while numerically precise, feels curiously…incomplete. It’s as if stating the precise number of grains of sand on a beach, without acknowledging the ocean itself. Let us, for a moment, consider the fund’s current constellation of holdings. At the apex, we find NYSEMKT:DFSD, a rather uninspired moniker, commanding $153.67 million (10.6% of AUM). Following closely is NYSEMKT:DFCF at $137.19 million (9.4%), then NYSEMKT:AVLV at $100.72 million (6.9%), VOO at $91.62 million (6.3%) and finally, DUHP at $77.90 million (5.4%). A predictable, if not entirely thrilling, assembly.

The connection, you see, is not merely numerical. It is a matter of perception, of the stories we tell ourselves about value.

They released their Q4 numbers on February 26th, and, well, they weren’t terrible. Solid, actually. But then the Middle East happened, and everything just…wobbled. The market, my portfolio, my general sense of wellbeing. It’s always something, isn’t it? The question is, can SoundHound shake it off and actually do something? Can it deliver on the hype? I’ve been doing a lot of thinking, and a lot of staring at charts (units of coffee consumed: 7. Hours spent questioning life choices: 4).

Now, they’re telling you to buy two of these things “hand over fist.” Sounds rather messy, doesn’t it? Like trying to catch eels. I’ve had a look, and I’ll tell you what I think. But be warned, I’m a bit of a grumblepuss when it comes to these financial contraptions.

The old guard, Brookfield Renewable Partners ([BEP 0.20%]), hasn’t done so well. A mere 9% bump, 40% total return. The difference is a quiet one, but it speaks volumes. Investors, it seems, prefer a cleaner ledger. A corporation, not a tangle of K-1s. It’s not about the money, see, it’s about the paperwork.

The transaction, detailed in a filing with the Securities and Exchange Commission – a document as thrilling as watching paint dry, yet occasionally revealing – leaves Immunovant occupying 11.4% of Alpine’s 13F AUM. A reduction, certainly, but hardly an abandonment. Consider, if you will, a collector deciding to part with a particularly iridescent, yet occasionally troublesome, butterfly from their collection. It remains a prized specimen, merely…less densely populated within the display case.